| P2093 | author name string | Louise Kuhn | |
| | Anna Coutsoudis | |
| | Brodie Daniels | |
| | Gita Ramjee | |
| | Photini Kiepiela | |
| | Shabashini Reddy | |
| | Elizabeth Spooner | |
| | Eshia Moodley-Govender | |
| | Linda Zako | |
| | Helen Mulol | |
| | Nhan T Ho | |
| P2860 | cites work | The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing | Q29615054 |
| | Laboratory information system data demonstrate successful implementation of the prevention of mother-to-child transmission programme in South Africa | Q30828683 |
| | High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, | Q33326481 |
| | Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis | Q34355499 |
| | Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries? | Q34368707 |
| | Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial | Q34369756 |
| | Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial | Q34634644 |
| | Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial | Q34748630 |
| | Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi | Q35452458 |
| | Health outcomes of HIV-exposed uninfected African infants | Q35825690 |
| | The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study | Q35935057 |
| | Eliminating mother-to-child HIV transmission in South Africa | Q36509402 |
| | Protection of the neonate by the innate immune system of developing gut and of human milk | Q36702572 |
| | Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania | Q36982435 |
| | Gut microbial colonisation in premature neonates predicts neonatal sepsis | Q37047543 |
| | Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol | Q37101067 |
| | Effect of presumptive co-trimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology and antibiotic resistance in Zambian infants: a longitudinal cohort study | Q37113259 |
| | Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease | Q37339874 |
| | Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants | Q37555921 |
| | The importance of the development of the intestinal microbiota in infancy | Q37601278 |
| | Breast milk as the gold standard for protective nutrients | Q37682382 |
| | Microbiota-stimulated immune mechanisms to maintain gut homeostasis | Q37775371 |
| | Rotavirus vaccination within the South African Expanded Programme on Immunisation. | Q38039610 |
| | Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana | Q38396143 |
| | Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial | Q38843857 |
| | Epidemiology of Acute Lower Respiratory Tract Infection in HIV-Exposed Uninfected Infants | Q40736639 |
| | Containing antimicrobial resistance: a renewed effort | Q42338259 |
| | Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy | Q43542964 |
| | Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection | Q43597700 |
| | Impact of cotrimoxazole prophylaxis on the health of breast-fed, HIV-exposed, HIV-negative infants in a resource-limited setting | Q43621620 |
| | Reduced thymic size but no evidence of impaired thymic function in uninfected children born to human immunodeficiency virus-infected mothers | Q45371185 |
| | Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana | Q46265061 |
| | Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants | Q46328518 |
| | Child mortality according to maternal and infant HIV status in Zimbabwe | Q46339318 |
| | Factors Affecting Gastrointestinal Microbiome Development in Neonates. | Q52679045 |
| | Evidence of impact of maternal HIV infection on immunoglobulin levels in HIV-exposed uninfected children. | Q53305666 |
| | 13-valent pneumococcal conjugate vaccine in Africa. | Q53739738 |
| | The role of the microbiome for human health: from basic science to clinical applications. | Q54214888 |
| | Development of the Pediatric Gut Microbiome: Impact on Health and Disease | Q58540603 |
| | Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses | Q58590807 |
| | Facilitators and barriers to cotrimoxazole and nevirapine prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe | Q59323401 |
| | Predictors of loss to follow up among HIV-exposed children within the prevention of mother to child transmission cascade, Kericho County, Kenya, 2016 | Q64135762 |
| | [Complementary feeding] | Q79368157 |
| | Effect of formula composition on the development of infant gut microbiota | Q84143418 |
| | Severe infections in HIV-exposed uninfected infants: clinical evidence of immunodeficiency | Q84229726 |
| | High Incidence of Invasive Group B Streptococcal Infections in HIV-Exposed Uninfected Infants | Q84791566 |
| | Role of the microbiome in human development | Q91167709 |
| P433 | issue | 12 | |
| P921 | main subject | sulfamethoxazole/trimethoprim | Q898623 |
| P304 | page(s) | e1717-e1727 | |
| P577 | publication date | 2019-12-01 | |
| P1433 | published in | The Lancet Global Health | Q27667673 |
| P1476 | title | Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial | |
| P478 | volume | 7 | |